-
1
-
-
0346628520
-
Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism
-
Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z, Wood WI 1989 Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 86:8083-8087
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 8083-8087
-
-
Godowski, P.J.1
Leung, D.W.2
Meacham, L.R.3
Galgani, J.P.4
Hellmiss, R.5
Keret, R.6
Rotwein, P.S.7
Parks, J.S.8
Laron, Z.9
Wood, W.I.10
-
2
-
-
0034705518
-
Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution
-
Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M, Amselem S 2000 Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 275:18664-18669
-
(2000)
J Biol Chem
, vol.275
, pp. 18664-18669
-
-
Pantel, J.1
Machinis, K.2
Sobrier, M.L.3
Duquesnoy, P.4
Goossens, M.5
Amselem, S.6
-
3
-
-
3042780191
-
A commonpolymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone
-
Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougnères P 2004 A commonpolymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
-
(2004)
Nat Genet
, vol.36
, pp. 720-724
-
-
Dos Santos, C.1
Essioux, L.2
Teinturier, C.3
Tauber, M.4
Goffin, V.5
Bougnères, P.6
-
4
-
-
0027475477
-
Expression and binding properties of two isoforms of the human growth hormone receptor
-
Sobrier ML, Duquesnoy P, Duriez B, Amselem S, Goossens M 1993 Expression and binding properties of two isoforms of the human growth hormone receptor. FEBS Lett 319:16-20
-
(1993)
FEBS Lett
, vol.319
, pp. 16-20
-
-
Sobrier, M.L.1
Duquesnoy, P.2
Duriez, B.3
Amselem, S.4
Goossens, M.5
-
5
-
-
0027178666
-
Functional characterization of the alternatively spliced, placental human growth hormone receptor
-
Urbanek M, Russell JE, Cooke NE, Liebhaber SA 1993 Functional characterization of the alternatively spliced, placental human growth hormone receptor. J Biol Chem 268:19025-19032
-
(1993)
J Biol Chem
, vol.268
, pp. 19025-19032
-
-
Urbanek, M.1
Russell, J.E.2
Cooke, N.E.3
Liebhaber, S.A.4
-
6
-
-
0025765004
-
A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor
-
Bass SH, Mulkerrin MG, Wells JA 1991 A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci USA 88:4498-4502
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 4498-4502
-
-
Bass, S.H.1
Mulkerrin, M.G.2
Wells, J.A.3
-
7
-
-
70349904753
-
Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: A systematic review and meta-analysis
-
Wassenaar MJ, Dekkers OM, Pereira AM, Wit JM, Smit JW, Biermasz NR, Romijn JA 2009 Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. J Clin Endocrinol Metab 94:3721-3730
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 3721-3730
-
-
Wassenaar, M.J.1
Dekkers, O.M.2
Pereira, A.M.3
Wit, J.M.4
Smit, J.W.5
Biermasz, N.R.6
Romijn, J.A.7
-
8
-
-
51649113457
-
Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly
-
Mercado M, González B, Sandoval C, Esquenazi Y, Mier F, Vargas G, de los Monteros AL, Sosa E 2008 Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly. J Clin Endocrinol Metab 93:3411-3415
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 3411-3415
-
-
Mercado, M.1
González, B.2
Sandoval, C.3
Esquenazi, Y.4
Mier, F.5
Vargas, G.6
de los7
Monteros, A.L.8
Sosa, E.9
-
9
-
-
0036800303
-
Growth hormone receptor antagonists: Discovery, development, and use in patients with acromegaly
-
Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ 2002 Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev 23:623-646
-
(2002)
Endocr Rev
, vol.23
, pp. 623-646
-
-
Kopchick, J.J.1
Parkinson, C.2
Stevens, E.C.3
Trainer, P.J.4
-
10
-
-
4544273108
-
Pegvisomant, a growth hormone-specific antagonist, undergoes cellular internalization
-
Maamra M, Kopchick JJ, Strasburger CJ, Ross RJ 2004 Pegvisomant, a growth hormone-specific antagonist, undergoes cellular internalization. J Clin Endocrinol Metab 89:4532-4537
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 4532-4537
-
-
Maamra, M.1
Kopchick, J.J.2
Strasburger, C.J.3
Ross, R.J.4
-
11
-
-
0035040522
-
Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer
-
Ross RJ, Leung KC, Maamra M, Bennett W, Doyle N, Waters MJ, Ho KK 2001 Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer. J Clin Endocrinol Metab 86:1716-1723
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1716-1723
-
-
Ross, R.J.1
Leung, K.C.2
Maamra, M.3
Bennett, W.4
Doyle, N.5
Waters, M.J.6
Ho, K.K.7
-
12
-
-
0029989302
-
Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization
-
Harding PA, Wang X, Okada S, Chen WY, Wan W, Kopchick JJ 1996 Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. J Biol Chem 271:6708-6712
-
(1996)
J Biol Chem
, vol.271
, pp. 6708-6712
-
-
Harding, P.A.1
Wang, X.2
Okada, S.3
Chen, W.Y.4
Wan, W.5
Kopchick, J.J.6
-
13
-
-
0035944825
-
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
-
van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO 2001 Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 358:1754-1759
-
(2001)
Lancet
, vol.358
, pp. 1754-1759
-
-
van der Lely, A.J.1
Hutson, R.K.2
Trainer, P.J.3
Besser, G.M.4
Barkan, A.L.5
Katznelson, L.6
Klibanski, A.7
Herman-Bonert, V.8
Melmed, S.9
Vance, M.L.10
Freda, P.U.11
Stewart, P.M.12
Friend, K.E.13
Clemmons, D.R.14
Johannsson, G.15
Stavrou, S.16
Cook, D.M.17
Phillips, L.S.18
Strasburger, C.J.19
Hackett, S.20
Zib, K.A.21
Davis, R.J.22
Scarlett, J.A.23
Thorner, M.O.24
more..
-
14
-
-
64549096004
-
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: Its efficacy in relation to gender and previous radiotherapy
-
Marazuela M, Lucas T, Alvarez-Escolá C, Puig-Domingo M, de la Torre NG, de Miguel-Novoa P, Duran-Hervada A, Manzanares R, Luque-Ramírez M, Halperin I, Casanueva FF, Bernabeu I 2009 Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy. Eur J Endocrinol 160:535-542
-
(2009)
Eur J Endocrinol
, vol.160
, pp. 535-542
-
-
Marazuela, M.1
Lucas, T.2
Alvarez-Escolá, C.3
Puig-Domingo, M.4
de la Torre, N.G.5
de Miguel-Novoa, P.6
Duran-Hervada, A.7
Manzanares, R.8
Luque-Ramírez, M.9
Halperin, I.10
Casanueva, F.F.11
Bernabeu, I.12
-
15
-
-
66949117381
-
Long term experience of pegvisomant therapy as a treatment for acromegaly
-
Higham CE, Chung TT, Lawrance J, Drake WM, Trainer PJ 2009 Long term experience of pegvisomant therapy as a treatment for acromegaly. Clin Endocrinol (Oxf) 71:86-91
-
(2009)
Clin Endocrinol (Oxf)
, vol.71
, pp. 86-91
-
-
Higham, C.E.1
Chung, T.T.2
Lawrance, J.3
Drake, W.M.4
Trainer, P.J.5
-
16
-
-
33847700931
-
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study
-
Schreiber I, Buchfelder M, Droste M, Forssmann K, Mann K, Saller B, Strasburger CJ 2007 Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study. Eur J Endocrinol 156:75-82
-
(2007)
Eur J Endocrinol
, vol.156
, pp. 75-82
-
-
Schreiber, I.1
Buchfelder, M.2
Droste, M.3
Forssmann, K.4
Mann, K.5
Saller, B.6
Strasburger, C.J.7
-
17
-
-
33645221483
-
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: Effect on IGF-I levels, tumor mass, hypertension and glucose tolerance
-
Colao A, Pivonello R, Auriemma RS, De Martino MC, Bidlingmaier M, Briganti F, Tortora F, Burman P, Kourides IA, Strasburger CJ, Lombardi G 2006 Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Eur J Endocrinol 154:467-477
-
(2006)
Eur J Endocrinol
, vol.154
, pp. 467-477
-
-
Colao, A.1
Pivonello, R.2
Auriemma, R.S.3
De Martino, M.C.4
Bidlingmaier, M.5
Briganti, F.6
Tortora, F.7
Burman, P.8
Kourides, I.A.9
Strasburger, C.J.10
Lombardi, G.11
-
18
-
-
15944375488
-
Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly
-
Jehle S, Reyes CM, Sundeen RE, Freda PU 2005 Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly. J Clin Endocrinol Metab 90:1588-1593
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 1588-1593
-
-
Jehle, S.1
Reyes, C.M.2
Sundeen, R.E.3
Freda, P.U.4
-
19
-
-
33846040409
-
Gender, body weight, disease activity, and previous radiotherapy influence the response to pegvisomant
-
Parkinson C, Burman P, Messig M, Trainer PJ 2007 Gender, body weight, disease activity, and previous radiotherapy influence the response to pegvisomant. J Clin Endocrinol Metab 92:190-195
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 190-195
-
-
Parkinson, C.1
Burman, P.2
Messig, M.3
Trainer, P.J.4
-
20
-
-
17744371632
-
Criteria for cure of acromegaly: A consensus statement
-
Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S 2000 Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 526-529
-
-
Giustina, A.1
Barkan, A.2
Casanueva, F.F.3
Cavagnini, F.4
Frohman, L.5
Ho, K.6
Veldhuis, J.7
Wass, J.8
Von Werder, K.9
Melmed, S.10
-
21
-
-
56049103301
-
Growth hormone (GH1) gene variation and the growth hormone receptor (GHR) exon 3 deletion polymorphism in a West-African population
-
Millar DS, Lewis MD, Horan M, Newsway V, Rees DA, Easter TE, Pepe G, Rickards O, Norin M, Scanlon MF, Krawczak M, Cooper DN 2008 Growth hormone (GH1) gene variation and the growth hormone receptor (GHR) exon 3 deletion polymorphism in a West-African population. Mol Cell Endocrinol 296:18-25
-
(2008)
Mol Cell Endocrinol
, vol.296
, pp. 18-25
-
-
Millar, D.S.1
Lewis, M.D.2
Horan, M.3
Newsway, V.4
Rees, D.A.5
Easter, T.E.6
Pepe, G.7
Rickards, O.8
Norin, M.9
Scanlon, M.F.10
Krawczak, M.11
Cooper, D.N.12
-
22
-
-
38449108652
-
Pegvisomant-induced lipohypertrophy: Report of a case with histopathology
-
Marazuela M, Daudén E, Ocón E, Moure D, Nattero L 2007 Pegvisomant-induced lipohypertrophy: report of a case with histopathology. Ann Intern Med 147:741-743
-
(2007)
Ann Intern Med
, vol.147
, pp. 741-743
-
-
Marazuela, M.1
Daudén, E.2
Ocón, E.3
Moure, D.4
Nattero, L.5
-
23
-
-
65549102025
-
Pegvisomant-induced cholestatic hepatitis with jaundice in a patient with Gilbert's syndrome
-
Bernabeu I, Cameselle-Teijeiro J, Casanueva FF, Marazuela M 2009 Pegvisomant-induced cholestatic hepatitis with jaundice in a patient with Gilbert's syndrome. Eur J Endocrinol 160:869-872
-
(2009)
Eur J Endocrinol
, vol.160
, pp. 869-872
-
-
Bernabeu, I.1
Cameselle-Teijeiro, J.2
Casanueva, F.F.3
Marazuela, M.4
-
24
-
-
32544437508
-
The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children
-
Binder G, Baur F, Schweizer R, Ranke MB 2006 The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab 91:659-664
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 659-664
-
-
Binder, G.1
Baur, F.2
Schweizer, R.3
Ranke, M.B.4
-
25
-
-
68349145046
-
D3 growth hormone receptor polymorphism is not associated with IGF-1 levels in untreated acromegaly
-
Kamenicky P, Dos Santos C, Espinosa C, Salenave S, Galland F, Le Bouc Y, Maison P, Bougnères P, Chanson P 2009 D3 growth hormone receptor polymorphism is not associated with IGF-1 levels in untreated acromegaly. Eur J Endocrinol 161:231-235
-
(2009)
Eur J Endocrinol
, vol.161
, pp. 231-235
-
-
Kamenicky, P.1
Dos Santos, C.2
Espinosa, C.3
Salenave, S.4
Galland, F.5
Le Bouc, Y.6
Maison, P.7
Bougnères, P.8
Chanson, P.9
-
26
-
-
34547625580
-
Growth hormone (GH) receptor isoform in acromegaly: Lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene
-
Schmid C, Krayenbuehl PA, Bernays RL, Zwimpfer C, Maly FE, Wiesli P 2007 Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene. Clin Chem 53:1484-1488
-
(2007)
Clin Chem
, vol.53
, pp. 1484-1488
-
-
Schmid, C.1
Krayenbuehl, P.A.2
Bernays, R.L.3
Zwimpfer, C.4
Maly, F.E.5
Wiesli, P.6
-
27
-
-
66749136426
-
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly
-
Bianchi A, Giustina A, Cimino V, Pola R, Angelini F, Pontecorvi A, De Marinis L 2009 Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J Clin Endocrinol Metab 94:2015-2022
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 2015-2022
-
-
Bianchi, A.1
Giustina, A.2
Cimino, V.3
Pola, R.4
Angelini, F.5
Pontecorvi, A.6
De Marinis, L.7
-
28
-
-
67849090089
-
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly
-
Bianchi A, Mazziotti G, Tilaro L, Cimino V, Veltri F, Gaetani E, Pecorini G, Pontecorvi A, Giustina A, De Marinis L 2009 Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. Pituitary 12:196-199
-
(2009)
Pituitary
, vol.12
, pp. 196-199
-
-
Bianchi, A.1
Mazziotti, G.2
Tilaro, L.3
Cimino, V.4
Veltri, F.5
Gaetani, E.6
Pecorini, G.7
Pontecorvi, A.8
Giustina, A.9
De Marinis, L.10
-
29
-
-
59749098582
-
Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency
-
Barbosa EJ, Palming J, Glad CA, Filipsson H, Koranyi J, Bengtsson BA, Carlsson LM, Boguszewski CL, Johannsson G 2009 Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency. J Clin Endocrinol Metab 94:639-644
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 639-644
-
-
Barbosa, E.J.1
Palming, J.2
Glad, C.A.3
Filipsson, H.4
Koranyi, J.5
Bengtsson, B.A.6
Carlsson, L.M.7
Boguszewski, C.L.8
Johannsson, G.9
-
30
-
-
33646253675
-
Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke
-
Horan M, Newsway V, Yasmin, Lewis MD, Easter TE, Rees DA, Mahto A, Millar DS, Procter AM, Scanlon MF, Wilkinson IB, Hall IP, Wheatley A, Blakey J, Bath PM, Cockcroft JR, Krawczak M, Cooper DN 2006 Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke. Hum Genet 119:527-540
-
(2006)
Hum Genet
, vol.119
, pp. 527-540
-
-
Horan, M.1
Newsway, V.2
Yasmin3
Lewis, M.D.4
Easter, T.E.5
Rees, D.A.6
Mahto, A.7
Millar, D.S.8
Procter, A.M.9
Scanlon, M.F.10
Wilkinson, I.B.11
Hall, I.P.12
Wheatley, A.13
Blakey, J.14
Bath, P.M.15
Cockcroft, J.R.16
Krawczak, M.17
Cooper, D.N.18
-
31
-
-
33845504692
-
Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA
-
Audí L, Esteban C, Carrascosa A, Espadero R, Pérez-Arroyo A, Arjona R, Clemente M, Wollmann H, Fryklund L, Parodi LA 2006 Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA. J Clin Endocrinol Metab 91:5038-5043
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 5038-5043
-
-
Audí, L.1
Esteban, C.2
Carrascosa, A.3
Espadero, R.4
Pérez-Arroyo, A.5
Arjona, R.6
Clemente, M.7
Wollmann, H.8
Fryklund, L.9
Parodi, L.A.10
-
32
-
-
33847279018
-
Regulation of growth hormone action by gonadal steroids
-
Meinhardt UJ, Ho KK 2007 Regulation of growth hormone action by gonadal steroids. Endocrinol Metab Clin North Am 36:57-73
-
(2007)
Endocrinol Metab Clin North Am
, vol.36
, pp. 57-73
-
-
Meinhardt, U.J.1
Ho, K.K.2
-
33
-
-
11244329010
-
-
Mercado M, Espinosa de los Monteros AL, Sosa E, Cheng S, Mendoza V, Hernández I, Sandoval C, Guinto G, Molina M 2004 Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Horm Res 62: 293-299
-
Mercado M, Espinosa de los Monteros AL, Sosa E, Cheng S, Mendoza V, Hernández I, Sandoval C, Guinto G, Molina M 2004 Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Horm Res 62: 293-299
-
-
-
-
34
-
-
34548279858
-
GHR exon 3 polymorphism: Association with type 2 diabetes mellitus and metabolic disorder
-
Strawbridge RJ,Kärvestedt L, Li C, Efendic S, Ostenson CG, Gu HF, Brismar K 2007 GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder. Growth Horm IGF Res 17:392-398
-
(2007)
Growth Horm IGF Res
, vol.17
, pp. 392-398
-
-
Strawbridge, R.J.1
Kärvestedt, L.2
Li, C.3
Efendic, S.4
Ostenson, C.G.5
Gu, H.F.6
Brismar, K.7
-
35
-
-
33845541643
-
Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults
-
Yuen KC, Dunger DB 2007 Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults. Diabetes Obes Metab 9:11-22
-
(2007)
Diabetes Obes Metab
, vol.9
, pp. 11-22
-
-
Yuen, K.C.1
Dunger, D.B.2
|